Edge Wealth Management LLC Anavex Life Sciences Corp. Transaction History

Edge Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 29, 2020	SELL	$2.31 - $3.14 $46,200 - $62,800	-20,000 Closed	0 $0
Q3 2019 Oct 21, 2019	SELL	$2.22 - $3.9 $22,200 - $39,000	-10,000 Reduced 33.33%	20,000 $63,000
Q1 2019 Apr 11, 2019	BUY	$1.68 - $3.42 $33,600 - $68,400	20,000 Added 200.0%	30,000 $91,000
Q2 2018 Jul 17, 2018	SELL	$2.08 - $4.26 $83,200 - $170,400	-40,000 Reduced 80.0%	10,000 $26,000
Q3 2017 Oct 19, 2017	BUY	$3.42 - $4.87 $171,000 - $243,500	50,000	50,000 $209,000

152

26.5M

674K

811K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $443M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.